This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Fresenius Kabi Austria Gmbh. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Claudio Crivaro and Bupivacaine Formulation Innovation.
Introduction
Claudio Crivaro is an inventor associated with Graz, Austria, and Fresenius Kabi Austria GmbH. His patent work concerns a ready-to-administer liquid formulation of bupivacaine.
Latest Patents
Crivaro is associated with 1 patent, titled “Bupivacaine Liquid Formulations.” The invention describes a liquid formulation containing bupivacaine or a pharmaceutically acceptable salt, along with methods for preparing the formulation and products that include it. The formulation may contain a tonicity agent, has an initial pH of about 4.2 to 4.5, and is described as stable and ready to administer.
Career Highlights
Crivaro’s listed patent activity is connected to pharmaceutical formulation development at Fresenius Kabi Austria GmbH. The invention focuses on a stable liquid medicine formulation designed for administration.
Collaborations
His listed coworkers include Christian Masser and Theofanis Mantourlias.
Conclusion
Claudio Crivaro’s patent contribution centers on a stable, ready-to-administer bupivacaine formulation developed in connection with Fresenius Kabi Austria GmbH.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile